Eicosanoids in Acute and Chronic Psoriatic Lesions: Leukotriene B4, but not 12-Hydroxy-Eicosatretraenoic Acid, Is Present in Biologically Active Amounts in Acute Guttate Lesions
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 92 (6), 837-841
- https://doi.org/10.1111/1523-1747.ep12696858
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE)Journal of the American Academy of Dermatology, 1988
- 15-Hydroxyeicosatetraenoic Acid (15-HETE) Specifically Inhibits LTB4-Induced Chemotaxis of Human NeutrophilsSkin Pharmacology and Physiology, 1988
- Leukotriene B4 fails to induce penetration of lymorphonuclear leukocytes into psoriatic lesionsBritish Journal of Dermatology, 1987
- Methotrexate Inhibits the Human C5a-Induced Skin Response in Patients With PsoriasisJournal of Investigative Dermatology, 1987
- Eicosanoids in Psoriasis – 15-HETE on the StageDermatology, 1987
- In Vitro Synthesis of 12-Hydroxy-eicosatetraenoic Acid Is Increased in Uninvolved Psoriatic EpidermisJournal of Investigative Dermatology, 1986
- Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesionsBiochemical and Biophysical Research Communications, 1986
- Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4British Journal of Dermatology, 1986
- Cutaneous Responses to 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid (12-HETE)Journal of Investigative Dermatology, 1985
- Structural identification of platelet activating factor in psoriatic scaleBiochemical and Biophysical Research Communications, 1985